The Next Chapter of AI Is an Infrastructure Story
This article argues that the future of AI development hinges on rethinking infrastructure to address growing concerns about energy consumption, heat management, and water usage. It emphasizes the need for collaboration across industries and with policymakers to adopt more efficient cooling technologies like liquid cooling, and to establish better metrics for resource use and community impact. The author, Denise Dignam, President and CEO of Chemours, asserts that prioritizing efficiency alongside performance will be crucial for the responsible and sustainable scaling of AI.
North Carolina's Cape Fear gets no PFAS fix in EPA's $450 million Chemours deal
A $450 million federal settlement between the EPA and Chemours over PFAS contamination is drawing criticism because it provides little direct cleanup relief for North Carolina's Cape Fear River residents. Much of the settlement is for pollution-control programs, and North Carolina is not set to receive the same water remediation as West Virginia and New Jersey, despite residents already having paid millions for filtration systems through water bills. Local advocates and state leaders, including Attorney General Jeff Jackson, argue the deal fails to hold Chemours accountable and burdens residents further.
CC - Chemours Company Latest SEC Filings
This article provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, valuation ratios, and insider/institutional ownership. It highlights a recent price drop of 5.61%, with the stock closing at $19.01, and includes various performance indicators over different timeframes, analyst recommendations, and an earnings surprise for the last quarter.
RBC Capital Remains a Buy on Chemours Company (CC)
RBC Capital analyst Arun Viswanathan reiterated a Buy rating on Chemours Company (CC) and set a price target of $26.00, indicating a potential upside from its closing price. The company also received a Moderate Buy consensus from analysts with an average price target of $25.15. This analysis follows the company's latest earnings report, which showed a quarterly revenue of $1.38 billion and a GAAP net loss of $29 million.
Chemours Reaches $450 Million PFAS Settlement
Chemours has reached a $450 million settlement with federal and state officials to address PFAS pollution at its facilities in West Virginia, North Carolina, and New Jersey. The agreement includes a $22.5 million civil penalty and hundreds of millions for projects to reduce PFAS releases, improve pollution control, and provide clean drinking water to affected communities. The settlement aims to cut down future contamination while allowing the company to continue essential PFAS production under tighter controls.
Is Chemours (CC) A Bargain As Its PFAS Settlement Clarifies Long Term Risks?
Chemours (CC) has agreed to a significant PFAS settlement, including a US$22.5 million civil penalty and US$90 million for long-term mitigation, which is expected to clarify its long-term liabilities. Despite a strong year-to-date share price increase of 64.41%, momentum has slowed, and the stock is still considered 24% undervalued with a fair value estimate of $26.33. The settlement improves earnings visibility and free cash flow conversion by reducing a major overhang of litigation risk.
Form 4 Chemours Co For: 1 July By Investing.com
This article announces the filing of a Form 4 for Chemours Co on July 1st. It also presents various financial market data including indices, commodities, bonds, and stock performances. The content is primarily a data feed from Investing.com, providing real-time financial updates.
Chemours (CC) director Courtney Mather receives 1,401 deferred stock units grant
Chemours director Courtney Mather was granted 1,401 deferred stock units as part of her board compensation. These units, valued at $20.52 each, are economically equivalent to Chemours common stock and increase her total deferred holdings to 8,983.8481 units. The deferred stock units will become payable in shares of common stock in the first month after her termination of service as a director, serving as long-term, non-cash compensation.
Governor, AG denounce EPA's Chemours settlement
North Carolina Governor Josh Stein and Attorney General Jeff Jackson have strongly criticized a proposed settlement between the EPA and Chemours regarding PFAS contamination. They assert that the deal, reached without consulting NC officials, disproportionately benefits West Virginia, leaving North Carolina with minimal resources despite being significantly affected by GenX contamination. Both officials emphasized that the agreement fails to adequately address the extensive environmental damage caused by Chemours in North Carolina and that the state will continue to pursue litigation against the company.
Mizuho Adjusts Price Target on Chemours to $25 From $30, Maintains Outperform Rating
Mizuho has adjusted its price target for Chemours (CC) to $25 from $30, while maintaining an Outperform rating on the stock. The article, published by MT Newswires, provides this analyst recommendation but the full content is reserved for members.
Price to sales forward of Chemours Company (The) – NYSE:CC
This page from TradingView provides financial information specifically focusing on the "Price to sales forward" metric for The Chemours Company (NYSE: CC). It appears to be a stub or data-focused page without detailed analytical text, primarily displaying the value and change of this financial metric, along with standard navigation and platform information.
Chemours would pay $11.25M to W.Va. under proposed settlement in federal case over PFAS discharges
Chemours could pay West Virginia more than $11 million as part of a proposed federal settlement requiring the company to pay $22.5 million in civil penalties for environmental violations, including PFAS discharges at its Washington Works plant. The settlement, which also mandates up to $90 million for PFAS mitigation and clean drinking water provisions, resolves a lawsuit brought by the EPA and West Virginia DEP. Environmental advocates view this as a significant win, shifting accountability to Chemours for contamination from "forever chemicals."
Price to sales forward of Chemours Co. – FWB:2CU
This article displays the "Price to sales forward" value for Chemours Co. (FWB:2CU) on the Frankfurt Stock Exchange. It provides a snapshot of this financial metric and is part of a larger financial data and analysis platform.
CC - Chemours Company Options
This page provides a detailed financial overview of The Chemours Company (CC), including its latest stock performance, key financial metrics, various ratios, and analyst recommendations. It highlights the company's market capitalization, income, sales, dividend information, and ownership details, alongside performance metrics over different timeframes.
Chemours agrees to $450 million forever chemicals settlement
The Chemours Company has reached a $450 million settlement with the US EPA and Justice Department regarding PFAS (forever chemicals) discharges. The settlement includes a $22.5 million civil penalty and $90 million for additional projects to reduce PFAS emissions and expand drinking water programs over the next 15 years. This agreement addresses long-standing environmental liability concerns that have impacted Chemours since its spinoff from DuPont.
Chemours Agrees to Controversial $452.5M Settlement Over PFAS Discharges
The Trump administration reached a $452.5 million settlement with Chemours Co. regarding unlawful discharges of PFAS "forever chemicals" in North Carolina, West Virginia, and New Jersey. This marks the first federal enforcement settlement against a PFAS maker, with Chemours facing a $22.5 million civil penalty and committing $90 million over 15 years to reduce PFAS discharges, including $280 million for clean drinking water near affected sites. The settlement, however, has drawn criticism from North Carolina's Attorney General, who called it "an insult" to the state's residents.
\'EPA has abandoned NC\': Local stakeholders dismayed by Chemours, feds’ settlement
Local leaders and advocates in North Carolina are expressing dismay over a $450 million settlement between the EPA, Chemours, and the Department of Justice, which they say lacks transparency and neglects North Carolina's water contamination issues. While some funds are allocated for mitigating chemical discharge in multiple states, only a small portion is for penalty fees, and North Carolina will not receive direct aid for its already polluted Cape Fear River. Environmental groups also highlight perceived conflicts of interest within the EPA and the potential for the settlement to hinder future accountability for Chemours.
Chemours agrees to $450M deal with feds, DEP over chronic multistate PFAS pollution
The Chemours Company has reached a $450 million settlement with federal and state authorities over violations of environmental laws related to PFAS pollution in West Virginia, North Carolina, and New Jersey. The agreement includes a $22.5 million civil penalty, significant investment in PFAS discharge limits, and provisions for clean drinking water in affected communities. This settlement follows a citizens' lawsuit and addresses a long history of industrial pollution, particularly from the Washington Works facility.
Chemours agrees to $450M PFAS settlement with US government
Chemours has reached a $450 million settlement with the U.S. Department of Justice, EPA, and West Virginia Department of Environmental Protection over claims of releasing PFAS "forever chemicals" into rivers from its facilities. The agreement includes a civil penalty, a multiyear program to mitigate toxic substance discharges, a PFAS pollution control system, and funds for clean drinking water in affected communities. This settlement follows a previous federal court order for Chemours to stop PFAS discharge from its Washington Works facility.
Chemours Must Cut Ohio River ‘Forever Chemical’ Pollution Under New Settlement. But a Fight Over Future Permit Limits Looms.
Chemours has reached a $450 million settlement with the Trump administration to reduce "forever chemical" pollution from its Wood County plant, including a $22.5 million fine and significant investments in upgrades and clean water initiatives. While environmental groups like the West Virginia Rivers Coalition praise the settlement, future battles are expected over the plant's renewed water discharge permit and proposed weakening of chemical limits by the Trump EPA. The agreement follows years of pollution violations and a federal court order prompted by the Rivers Coalition's lawsuit.
Stein to Chemours: ‘Pay to help us clean up the pollution’
North Carolina officials and environmental groups are criticizing Chemours' proposed $450 million federal settlement over PFAS pollution, arguing that it will do little to benefit the state. Governor Josh Stein expressed concerns that North Carolina may not receive any funds from the deal, despite being one of the three states named in the agreement. Environmental advocates emphasize the need for Chemours and DuPont to fund the cleanup of existing pollution in communities rather than relying on the current settlement terms.
Chemours would pay $11.25M to WV under proposed settlement in federal case over PFAS discharges
Chemours is facing a proposed settlement of $22.5 million in civil penalties for violating environmental laws by discharging PFAS "forever chemicals" at several facilities, including one in West Virginia. Under the proposal, West Virginia would receive $11.25 million, and Chemours would also be required to spend up to $90 million over 15 years to mitigate PFAS discharges and potentially provide clean drinking water to affected communities. While the settlement resolves allegations without an admission of liability from Chemours, it is seen as a win by environmental advocates for safeguarding water resources and holding polluters accountable.
U.S. says chemical maker Chemours to pay $450 million to settle ‘forever chemicals’ case
The Trump administration has reached a $450 million multistate settlement with Chemours to address illegal discharges of "forever chemicals" (PFAS) in West Virginia, North Carolina, and New Jersey. The agreement mandates penalties, cleanup measures, new treatment systems, and the provision of clean drinking water to affected communities. While the Justice Department praises the settlement for protecting public health, North Carolina's attorney general criticizes it as inadequate for communities dealing with GenX contamination.
Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS
The Chemours Company has reached a settlement with the U.S. EPA and the West Virginia Department of Environmental Protection (WVDEP) to resolve claims related to PFAS discharges and other compliance issues at three of its facilities. The agreement includes a $22.5 million civil penalty and $90 million in additional mitigation projects over 15 years to reduce PFAS emissions and enhance off-site drinking water programs. This settlement aligns with Chemours' "Pathway to Thrive" strategy, aiming for long-term responsible manufacturing and a 99% reduction in fluorinated organic chemical emissions by 2030.
Chemours looks to settle federal PFAS case for $450 million. NC wasn’t at the table.
The U.S. Department of Justice announced a proposed $450 million settlement with chemical manufacturer Chemours over PFAS contamination in three states, including North Carolina. However, North Carolina officials, led by Gov. Josh Stein and Attorney General Jeff Jackson, have criticized the deal as a "backroom deal" that offers virtually nothing for their state, despite North Carolina housing the only GenX-producing facility in the U.S. The settlement funds allocated to North Carolina are considered minuscule compared to the actual costs incurred for PFAS remediation and research, leading to concerns about the state's ability to hold Chemours accountable for ongoing pollution.
Chemours Agrees to $450M settlement agreement in West Virginia, North Carolina, and New Jersey
Chemours, a spin-off of DuPont, has reached a multi-state settlement with the Justice Department, Environmental Protection Agency, and the West Virginia Department of Environmental Protection. The agreement requires Chemours to pay a $22.5 million civil penalty and implement a multi-year, $90 million program to mitigate PFAS discharges from its facilities in West Virginia, North Carolina, and New Jersey. The total cost of the settlement, including penalties and injunctive relief programs to prevent future contamination and provide clean drinking water, is estimated to exceed $450 million over 15 years.
North Carolina leaders say federal Chemours deal fails Cape Fear region
North Carolina Governor Josh Stein and Attorney General Jeff Jackson are criticizing a proposed federal settlement with Chemours, stating it inadequately addresses PFAS contamination in the Cape Fear region. They argue the deal, which offers $90 million over 15 years for water cleanup in three states, was negotiated without state input and provides no guarantee of significant funding for North Carolina. Local advocacy groups also express suspicion regarding the agreement's lack of accountability.
Trump admin reaches settlement with major PFAS maker
The Trump administration and West Virginia have reached a proposed $22.5 million settlement with chemical giant Chemours for illegal discharges of PFAS "forever chemicals." The agreement also includes up to $90 million for environmental mitigation projects. While hailed by the Justice Department as a landmark deal, North Carolina, a state significantly impacted by Chemours' pollution, has criticized the agreement as "an insult."
US says chemical maker Chemours to pay $450M to settle 'forever chemicals' case
The Trump administration has reached a multi-state settlement with Chemours Co., requiring the chemical giant to pay $450 million to resolve claims related to the illegal discharge of "forever chemicals" (PFAS). The settlement includes a civil penalty of $22.5 million, $90 million over 15 years to mitigate PFAS discharges in West Virginia, North Carolina, and New Jersey, and additional costs for pollution controls and clean drinking water. While the Justice Department hails the agreement as protecting public health, North Carolina's Attorney General criticizes it as an "insult" for not adequately addressing contamination in his state.
Trump administration settles water pollution case with ‘forever chemicals’ company for $450M
The federal government has reached a $450 million settlement with Chemours, a company that produces "forever chemicals" (PFAS), to resolve a water pollution case. The Justice Department, EPA, and the state of West Virginia announced on Wednesday that Chemours will pay a civil penalty, fund a mitigation program, install pollution controls, and provide clean drinking water in communities affected by contamination in West Virginia, North Carolina, and New Jersey. The settlement allows Chemours to continue manufacturing PFAS for critical applications while addressing the environmental and health impacts of its past releases.
U.S. says chemical maker Chemours to pay $450M to settle ‘forever chemicals’ case
The Trump administration has reached a multistate settlement with Chemours Co. for $450 million to resolve violations stemming from illegal discharges of "forever chemicals" (PFAS). The agreement includes a $22.5 million civil penalty and requires Chemours to spend $90 million over 15 years on mitigation efforts, install pollution controls, and provide clean drinking water in West Virginia, North Carolina, and New Jersey. This marks the first federal settlement against a major PFAS manufacturer, though North Carolina's Attorney General criticized it as insufficient.
Chemours reaches settlement over PFAS contamination in North Carolina
Chemours has reached a landmark settlement with the federal government regarding PFAS contamination in four states, including North Carolina. The company will pay a $22.5 million civil penalty and invest over $370 million in mitigation and clean water programs, which includes reducing PFAS discharges at its Fayetteville Works facility and providing clean drinking water to affected communities. This agreement marks the first federal settlement specifically addressing "forever chemical" pollution by a manufacturer.
NC Attorney General Jackson on Chemours, EPA agreement: 'This is an insult' to eastern NC
North Carolina Attorney General Jeff Jackson has strongly criticized a proposed consent decree between Chemours and the U.S. Environmental Protection Agency regarding PFAS contamination, calling it an "insult" to eastern NC. Jackson argues the agreement does little for the state, neglects groundwater contamination, and is overly favorable to Chemours, especially compared to an existing state-level decree that has already led to significant emission reductions. He believes the EPA has failed to hold Chemours adequately accountable, highlighting that the state's Department of Justice was not involved in the negotiations.
US says chemical maker Chemours to pay $450M to settle 'forever chemicals' case
The Trump administration has finalized a multi-state settlement with Chemours Co. regarding alleged illegal discharges of PFAS "forever chemicals." The agreement requires Chemours to pay a $22.5 million civil penalty and invest an estimated $90 million over 15 years to reduce PFAS contamination in specific regions, with the total value of penalties and cleanup efforts estimated at $450 million. This settlement marks the first time the federal government has resolved enforcement claims against a major PFAS manufacturer.
Chemours agrees to $450 million settlement with US Justice Department over chemical release
The Chemours Company has reached a $450 million settlement with the U.S. Department of Justice concerning the release of "forever chemicals" (PFAS) in West Virginia, North Carolina, and New Jersey. This settlement is the first comprehensive agreement by the federal government to address enforcement claims against a manufacturer of these chemicals. Chemours will pay a $22.5 million civil penalty and provide $90 million for PFAS control and removal from drinking water, while also committing to operational improvements at its facilities.
US says chemical giant Chemours to pay $450m to settle ‘forever chemicals’ case
The Trump administration has reached a multi-state settlement with Chemours Co, a chemical giant, to resolve enforcement claims against it for illegal discharges of "forever chemicals" (Pfas). Under the agreement, Chemours will pay $22.5 million in penalties and spend an estimated $450 million in total on mitigation efforts across West Virginia, North Carolina, and New Jersey. This settlement is the first by the federal government against a major Pfas manufacturer and aims to prevent future contamination while allowing Chemours to continue its commercial and military operations.
Chemours faces more than $450M in costs under landmark PFAS settlement (CC:NYSE)
The Chemours Company (CC) has agreed to a settlement requiring over $450 million for penalties, pollution controls, and community water programs related to PFAS contamination. This landmark agreement provides some clarity on its financial liabilities but does not eliminate all future legal, regulatory, and remediation risks. Chemours must also implement operational changes including reduced PFAS discharges and enhanced monitoring.
US says chemical maker Chemours to pay $450M to settle 'forever chemicals' case
The Trump administration has reached a multi-state settlement with Chemours Co. over illegal discharges of "forever chemicals" (PFAS), marking the federal government's first enforcement claim against a PFAS manufacturer. Chemours will pay a civil penalty of $22.5 million and spend $90 million over 15 years to mitigate PFAS discharges in West Virginia, North Carolina, and New Jersey. The total value of penalties and relief programs is estimated at $450 million. The settlement allows Chemours to continue manufacturing PFAS for commercial and military applications while addressing ongoing pollution concerns.
Chemours Co (CC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Chemours Co (CC), detailing its price momentum score, current support and resistance levels, and the readings from various technical indicators and moving averages. The analysis suggests a neutral signal for the stock based on these indicators, noting the stock is suitable for range-bound swing trading.
Chemours Co (CC) Earnings Forecast: Future EPS & Revenue Growth Estimates
The Chemours Co (CC) currently holds an earnings forecast score of 6.80, ranking 45th in the Chemicals industry. Analysts estimate a target price of $15.00, with a high of $19.00 and a low of $13.00, and a general "Hold" rating from 10 analysts. The expected revenue for the next quarter is $1.65 billion, with anticipated EPS of $0.40.
The Chemours Co (CC) Stock Down 3.4% but Still Overvalued -- GF Score: 66/100
The Chemours Co (CC) saw its shares drop by 3.4% to $21.67, but the stock is still considered overvalued by GuruFocus, with its current price 9.2% above the intrinsic value estimate of $19.84. The company has a GF Score of 66/100, driven by its profitability but hindered by weak financial strength and lack of recent insider transactions, suggesting caution for potential investors. Its current P/E ratio of 16.6x is also significantly higher than its 5-year median.
Chemours (CC) Stock Valuation Check After Recent Volatility And Undervaluation Debate
Chemours (CC) stock has experienced recent volatility, closing at US$21.52, but a common valuation narrative suggests it is significantly undervalued with a fair value of $26.33. This undervaluation is supported by increasing demand for its Opteon refrigerants due to regulatory changes, leading to strong sales and margin recovery, provided that PFAS litigation and TiO2 market competition do not negatively impact its cash flow and margins. Investors are advised to consider the rewards and warnings signs for Chemours, as well as other investment opportunities in materials-related stocks.
Chemours Award Highlights Research Culture And Long Term Investor Considerations
Chemours (NYSE: CC) has launched its first "Catalyst for Scientific Excellence Award" to recognize internal researchers, signaling a strategic focus on its science-driven culture and talent retention. This move is presented as a data point for investors, suggesting potential long-term benefits for the company's product pipeline and competitive strength, despite current financial risks like interest payment coverage. The article encourages investors to monitor concrete outcomes linked to these awards, such as new product launches or patents, to gauge their impact.
A Look at The Chemours Co (CC) After 4.2% Decline -- GF Value $1
The Chemours Co (CC) shares recently declined by 4.2%, trading at $21.67, which is 9.4% above its GF Value™ estimate of $19.81, suggesting it is overvalued. The company holds a GF Score™ of 66/100, indicating moderate potential for long-term returns, though it shows poor financial strength. A lack of insider transactions further suggests a cautious outlook for the stock.
Federal appeals court throws out Chemours pollution injunction
A federal appeals court has overturned an injunction that required Chemours' Washington Works facility to stop exceeding its pollution limits in the Ohio River. The court found errors in the lower court's analysis of "irreparable harm," stating it improperly considered harm to the general public instead of focusing on the plaintiff's specific injury. Despite the ruling, the West Virginia Rivers Coalition plans to continue pursuing civil penalties, and Chemours stated it would continue to comply with permit limits, as it has since the initial injunction.
Attorney General Jeff Jackson Defends Antitrust Enforcement in Chemours Case
Attorney General Jeff Jackson is advocating for comprehensive antitrust enforcement in the Fourth Circuit Court of Appeals, arguing that alleged anticompetitive conduct should be evaluated as a whole, not piecemeal. He filed an amicus brief in a case involving Chemours, which is accused of illegally monopolizing the HVAC refrigerant market. Jackson emphasizes that proper enforcement of antitrust laws is crucial to protect consumers from higher prices and fewer choices and has a history of pursuing companies for anticompetitive behavior.
Chemours Award Highlights Research Culture And Long Term Investor Considerations
Chemours (NYSE:CC) has launched its first Catalyst for Scientific Excellence Award to recognize internal researchers for their contributions to innovation and knowledge sharing. This initiative signals the company's commitment to fostering a stronger science-driven culture and efficient knowledge transfer, which could enhance its product pipeline and competitive strength. While the company faces financial challenges, the award is seen as a positive cultural indicator that might attract and retain talent, potentially supporting future growth and long-term value creation.
Chemours (CC) Down 4.5% Since Last Earnings Report: Can It Rebound?
Chemours (CC) shares have dropped 4.5% since its last earnings report, underperforming the S&P 500. The company's Q1 2026 earnings surpassed estimates, but revenues missed, impacted by mixed segment performances. Despite a downward trend in estimates, Chemours expects sequential sales growth for Q2 and maintains its full-year 2026 outlook.
Appeals court overturns ruling to stop Chemours from polluting the Ohio River
A federal appeals court has overturned a ruling that required the Chemours Chemical Company to cease violating its water pollution permit at its Washington Works plant along the Ohio River. The 4th U.S. Circuit Court of Appeals stated that the lower court's ruling was based on a faulty analysis of "irreparable harm" and that simply violating a permit does not automatically constitute such harm. Chemours stated it has been complying with the previous order since August and will continue to operate safely and in compliance with discharge permit limits.
Chemours (CC) Down 4.5% Since Last Earnings Report: Can It Rebound?
Chemours (CC) shares have dropped 4.5% since its last earnings report, underperforming the S&P 500. The company reported a Q1 2026 net loss but earnings per share surpassed estimates, while revenues missed. The article discusses segment performances, financial details, and Chemours' outlook for Q2 and the full year 2026, noting a downward trend in analyst estimates.
